Skip to content

5-MeO-DMT: all studies

Page 41 of 112: studies 401 to 410 of 1,115, newest first. Back to the 5-MeO-DMT overview

Research

Isolation and Characterization of Bioactive Amines from Mimosa tenuiflora (Willd.) Poir. of Brazilian Origin

The Natural Products Journal August 12, 2026 Weslany Souza Rocha, João Xavier de Araújo‐Júnior, Edeildo Ferreira da Silva‐Júnior et al.

Introduction: Mimosa tenuiflora (Willd.) Poir., widely known as Jurema preta in Brazil and tepezcohuite in Mexico, is a perennial shrub or tree traditionally used in folk medicine across the Caatinga biome of northeastern Brazil and other regions of Central and South America. Tryptamine is an indole alkaloid naturally found in several species, with M. tenuiflora representing an important...

The Australian Ayahuasca Dietero Networks: Culture, Community, and Practices

Contemporary Drug Problems August 11, 2026 Alana Roy, M.l. Williams, Kimberley Day et al.

Alternative healthcare practices using psychedelic “plant medicines,” such as ayahuasca, challenge current prohibition and mainstream healthcare frameworks. Despite the criminalization of ayahuasca's active component, N,N-dimethyltryptamine (DMT), Australian ayahuasca dietero networks have developed sophisticated healthcare systems with systematic assessment processes, safety mechanisms, and...

Psychological change processes in alcohol use disorder: A qualitative study of 5‐methoxy‐ N , N ‐dimethyltryptamine (5‐MeO‐DMT) with cognitive behavioural therapy

Addiction August 3, 2026 Mathieu Seynaeve, Fiona Dunbar, Anna O. Ermakova et al.

BACKGROUND AND AIMS: This study qualitatively explored psychological change processes as described by participants and therapists within a phase 2a clinical trial evaluating the safety, tolerability, and preliminary efficacy of a single dose of intranasal 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT; BPL-003) administered alongside psychological support and manualised cognitive behavioural...

Klassische Halluzinogene in der Behandlung von Suchterkrankungen – Ein narrativer Überblick

Suchttherapie August 1, 2026 Yann David Kippe, Christopher Poppe, Dimitris Repantis et al.

Zusammenfassung Klassische Halluzinogene („Psychedelika“) wie Lysergsäurediethylamid (LSD), Psilocybin, N,N-Dimethyltryptamin (DMT) und 5-Methoxydimethyltryptamin (5-MeO-DMT) werden zurzeit wieder als potenzielle Behandlungsoptionen bei Substanzgebrauchsstörungen untersucht. Psychedelika entfalten ihre Wirkung über eine Aktivierung von serotonergen 5HT-2a Rezeptoren im zentralen Nervensystem,...

The Experience-Trajectory Framework: Substance-Specific Risk Stratification for Psychedelic Preparation and Aftercare Beyond Set and Setting

International Journal For Multidisciplinary Research July 31, 2026 Eric P. Rubenstein

Set, setting, preparation, and integration are widely recognized as important dimensions of psychedelic experiences. However, these concepts often remain too general to specify how preparation, containment, and aftercare should differ across substances, routes of administration, acute duration, residual effects, bodily condition, and interaction exposure. This article proposes the...

Visionary art and the limits of social constructivism

Visual Studies July 16, 2026 Orsolya Bajusz

Visionary art, inspired by the shift in perspective towards a (hyper)spatial horizon, represents a departure from the postmodern ethos. Rather than simply remixing established cultural signifiers, these images function as portals to divergent ontological realms and non-human visual paradigms. Focusing on the agency of non-human entities and dimensions, this paper proposes a new methodology for...

DOI: 10.1080/1472586x.2026.2697924 (opens in new tab) Semiotics Agency philosophy Postmodernism Perspective graphical +9

Sex-dependent effects of psychedelics: review of evidence from rodent models

Frontiers in Psychiatry July 15, 2026 Rafał Marecki, Wiktoria Zaniewska, Adam Hamed et al.

Classic psychedelics, including psilocybin, LSD, DMT, 5-MeO-DMT, mescaline, and phenethylamines such as DOI, exert their core effects through 5-HT2A receptor agonism, inducing widespread neurobiological and behavioral changes relevant to psychiatric research. Emerging evidence suggests that these effects are modulated by sex, yet this dimension remains underrepresented in studies. This review...

DOI: 10.3389/fpsyt.2026.1824073 (opens in new tab) Serotonergic Prepulse inhibition Anhedonia Schizophrenia object-oriented programming +10

Combined DMT-harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers.

Psychopharmacology July 14, 2026 Helena Aicher, Joëlle Dornbierer, Luzia Caflisch et al.

Negative self-referential emotions such as embarrassment and shame play a key role in the psychopathology of psychiatric disorders but are often insufficiently addressed by standard treatments. Psychedelics such as ayahuasca - an Amazonian plant decoction containing the psychedelic N,N-dimethyltryptamine (DMT) and harmala alkaloids, have been proposed to positively modulate self-referential...

DOI: 10.1007/s00213-026-07118-4 (opens in new tab) Full text (opens in new tab) Embarrassment Hallucinogens Harmine N,N-Dimethyltryptamine +3

Psychedelic-Assisted Psychosexual Therapy

July 10, 2026 Lohani Noor

A resurgent therapeutic frontier, the contemporary renaissance in psychedelic science has accelerated investigation of classic serotonergic psychedelics (psilocybin, lysergic acid diethylamide (LSD), N,N-dimethyltryptamine (DMT), mescaline), empathogenic entactogenic agents (3,4-methylenedioxymethamphetamine (MDMA)), and glutamatergic dissociatives (ketamine) as adjuncts to psychotherapy. While...

Epigenetic landscapes of classical psychedelics and ketamine: molecular mechanisms of long-lasting neuromodulation

Molecular Psychiatry July 10, 2026 Cong Lin, Xiaohui Wang

Classic psychedelics such as lysergic acid diethylamide (LSD), psilocybin, N,N-dimethyltryptamine (DMT), and mescaline induce lasting changes in neuroplasticity and behavior that extend far beyond their acute pharmacological effects. Emerging evidence highlights that these enduring therapeutic benefits in neuropsychiatric conditions may be significantly mediated through complex epigenetic...